ITTO20130663A1 - Sistema di somministrazione transdermico per l'impiego nel trattamento di patologie croniche bronco-polmonari - Google Patents

Sistema di somministrazione transdermico per l'impiego nel trattamento di patologie croniche bronco-polmonari

Info

Publication number
ITTO20130663A1
ITTO20130663A1 IT000663A ITTO20130663A ITTO20130663A1 IT TO20130663 A1 ITTO20130663 A1 IT TO20130663A1 IT 000663 A IT000663 A IT 000663A IT TO20130663 A ITTO20130663 A IT TO20130663A IT TO20130663 A1 ITTO20130663 A1 IT TO20130663A1
Authority
IT
Italy
Prior art keywords
polmonary
bronco
pathologies
chronic
treatment
Prior art date
Application number
IT000663A
Other languages
English (en)
Inventor
Alberto Giraudi
Giovanni Giraudi
Original Assignee
Abc Farmaceutici S P A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abc Farmaceutici S P A filed Critical Abc Farmaceutici S P A
Priority to IT000663A priority Critical patent/ITTO20130663A1/it
Priority to PCT/IB2014/063610 priority patent/WO2015015459A1/en
Priority to CN201480043856.5A priority patent/CN105451715B/zh
Priority to US14/908,701 priority patent/US20160184312A1/en
Priority to EP14781670.6A priority patent/EP3027173B1/en
Publication of ITTO20130663A1 publication Critical patent/ITTO20130663A1/it
Priority to US15/936,515 priority patent/US20180280400A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M2037/0007—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin having means for enhancing the permeation of substances through the epidermis, e.g. using suction or depression, electric or magnetic fields, sound waves or chemical agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Medical Informatics (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IT000663A 2013-08-02 2013-08-02 Sistema di somministrazione transdermico per l'impiego nel trattamento di patologie croniche bronco-polmonari ITTO20130663A1 (it)

Priority Applications (6)

Application Number Priority Date Filing Date Title
IT000663A ITTO20130663A1 (it) 2013-08-02 2013-08-02 Sistema di somministrazione transdermico per l'impiego nel trattamento di patologie croniche bronco-polmonari
PCT/IB2014/063610 WO2015015459A1 (en) 2013-08-02 2014-08-01 Transdermal administration system for use in the treatment of chronic bronchopulmonary diseases
CN201480043856.5A CN105451715B (zh) 2013-08-02 2014-08-01 用于治疗慢性支气管肺病的经皮给药系统
US14/908,701 US20160184312A1 (en) 2013-08-02 2014-08-01 Transdermal administration system for use in the treatment of chronic bronchopulmonary diseases
EP14781670.6A EP3027173B1 (en) 2013-08-02 2014-08-01 Transdermal administration system for use in the treatment of chronic bronchopulmonary diseases
US15/936,515 US20180280400A1 (en) 2013-08-02 2018-03-27 Transdermal administration system for use in the treatment of chronic bronchopulmonary diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000663A ITTO20130663A1 (it) 2013-08-02 2013-08-02 Sistema di somministrazione transdermico per l'impiego nel trattamento di patologie croniche bronco-polmonari

Publications (1)

Publication Number Publication Date
ITTO20130663A1 true ITTO20130663A1 (it) 2015-02-03

Family

ID=49304223

Family Applications (1)

Application Number Title Priority Date Filing Date
IT000663A ITTO20130663A1 (it) 2013-08-02 2013-08-02 Sistema di somministrazione transdermico per l'impiego nel trattamento di patologie croniche bronco-polmonari

Country Status (5)

Country Link
US (2) US20160184312A1 (it)
EP (1) EP3027173B1 (it)
CN (1) CN105451715B (it)
IT (1) ITTO20130663A1 (it)
WO (1) WO2015015459A1 (it)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106420674A (zh) * 2016-11-11 2017-02-22 邓蜀俐 用于治疗呼吸类疾病的透皮贴剂的药物组合物及透皮贴剂

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007066151A2 (en) * 2005-12-07 2007-06-14 Pharmakodex Ltd Topical compositions for treatment of respiratory disorders
WO2007120485A2 (en) * 2006-03-30 2007-10-25 Cinergen, Llc Methods of treating pain with alkylxanthines and antiepileptics and compositions for use therefor

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US6331543B1 (en) * 1996-11-01 2001-12-18 Nitromed, Inc. Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007066151A2 (en) * 2005-12-07 2007-06-14 Pharmakodex Ltd Topical compositions for treatment of respiratory disorders
WO2007120485A2 (en) * 2006-03-30 2007-10-25 Cinergen, Llc Methods of treating pain with alkylxanthines and antiepileptics and compositions for use therefor

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ADEMOLA J I ET AL: "CUTANEOUS METABOLISM OF THEOPHYLLINE BY THE HUMAN SKIN", JOURNAL OF INVESTIGATIVE DERMATOLOGY, vol. 98, no. 3, 1992, pages 310 - 314, XP002722925, ISSN: 0022-202X *
THAKUR RASHMI A ET AL: "Transdermal and buccal delivery of methylxanthines through human tissue in vitro.", DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY MAY 2007, vol. 33, no. 5, May 2007 (2007-05-01), pages 513 - 521, XP002722924, ISSN: 0363-9045 *

Also Published As

Publication number Publication date
CN105451715A (zh) 2016-03-30
EP3027173A1 (en) 2016-06-08
CN105451715B (zh) 2018-10-09
EP3027173B1 (en) 2018-07-25
US20180280400A1 (en) 2018-10-04
WO2015015459A1 (en) 2015-02-05
US20160184312A1 (en) 2016-06-30

Similar Documents

Publication Publication Date Title
EP2948896A4 (en) OPTIMIZED SYSTEM FOR DISPENSING A BIOSYNCHRONOUS BIOACTIVE MEDIUM
EP2991711A4 (en) DRUGS CHARGE DEVICE
EP2968829A4 (en) BEFEUCHTERBEHÄLTER
IL245540A0 (en) Systems, devices and methods for the creation of a therapeutic restriction in the gastrointestinal tract
EP2943137C0 (en) SURGICAL AUXILIARY DEVICE
HUE054783T2 (hu) Pridopidin Huntington-kór kezelésében
DK2983721T4 (da) Terapeutiske indgivelsesvesikler
DK3062849T3 (da) Medikamentadministrationsanordning
PL2852391T3 (pl) Układy do leczenia infekcji płuc
HUE056006T2 (hu) Kombináció Parkinson-kór kezelésére
LT2945642T (lt) Faktoriaus 1 baltymas, skirtas naudoti ligų gydymui arba prevencijai
HUE053906T2 (hu) SGLT2-inhibitorok macskafélék közé tartozó állatok anyagcsere-rendellenességeinek kezelésére
EP2950785A4 (en) NANOPARTICLE-drug delivery systems
EP2968137A4 (en) EMULSION FORMULATIONS
EP2957313A4 (en) BREATHING ASSISTANCE DEVICE
EP3334413A4 (en) DISPENSER
HRP20181554T4 (hr) Tauroursodezoksikolna kiselina (tudca), namijenjena upotrebi u liječenju neurodegenerativnih poremećaja
BR112016014512A2 (pt) formulações farmacêuticas líquidas de pemetrexede
EP2964185A4 (en) PREPARATIONS FOR TREATMENT OF SLEEP RELATED ATMOSPHERES
HUE045148T2 (hu) Bumetanid parkinson-szindrómás neurodegeneratív betegségek kezelésére
HUE071419T2 (hu) Gyógyászati szénhidrát készítmény terápiás alkalmazásra
ITTO20130663A1 (it) Sistema di somministrazione transdermico per l'impiego nel trattamento di patologie croniche bronco-polmonari
ES1096233Y (es) Sistema de tratamiento de agua
EP2977076A4 (en) DEVICE FOR TRANSDERMAL ADMINISTRATIONS
ITTO20130972A1 (it) Unita' per la distribuzione di fluidi